Advertisement
Screener

BioLife Solutions, Inc. (BLFS) Debt / Equity

BioLife Solutions, Inc. (BLFS) Debt / Equity

  • 2026-06-30: Debt/Equity Ratio 0.
  • 2026-03-31: Debt/Equity Ratio 0.01.
  • 2025-12-31: Debt/Equity Ratio 0.01.
  • 2025-09-30: Debt/Equity Ratio 0.02.

Complete source-backed debt/equity ratio history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2026-06-300
2026-03-310.01
2025-12-310.01
2025-09-300.02
2025-06-300.03
2025-03-310.04
2024-12-310.05
2024-09-300.06
2024-06-300.07
2024-03-310.07
2023-12-310.07
2023-09-300.08
2023-06-300.07
2023-03-310.07
2022-12-310.07
2022-09-300.06
2022-06-300.02
2022-03-310.01
2021-12-310.02
2021-09-300.02
2021-06-300.02
2020-12-310.01

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2025-12-310.01
2024-12-310.05
2023-12-310.07
2022-12-310.07
2021-12-310.02
2020-12-310.01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Axogen, Inc. (AXGN)United States$2.329B-73.83
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B